Stock screenerAll disclosures →
EDGAR →
CTNM
Conviction 71HealthcareScan · Thu, Jun 25, 2026CTNM$13.37+4.25%
ResistanceSupportVol 14Insider sell2
Vol MA14 277.84K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price13.37
Change+4.25%
Gap+2.34%
Rel volume2.39×
Avg volume256.76K
Avg $ vol3.17M
SMA 2012.28
SMA 5013.00
SMA 20012.52
Price vs 50+2.81%
Price vs 200+6.71%
MA stackbullish
50/200 cross—
Supertrenddown · 13.96
RSI (14)58
MACD hist0.15
MACD crossbull · 2d
Stoch %K / %D89 / 67
ADX (14)13
+DI / −DI20 / 15
RSI divergence—
MACD divergence—
ATR %+7.00%
ADR %7.31%
52w high16.00
52w low3.73
From 52w high-16.47%
Above 52w low+258.31%
New 52w highNo
SqueezeOff
Bollinger width21.64%
%B0.91
Donchian pos89.05%
Donchian high13.64
Donchian low11.17
AVWAP (52w high)13.17
vs AVWAP high+1.52%
AVWAP (52w low)11.13
vs AVWAP low+20.08%
OBV trendFlat
Chaikin MF (20)-0.18
Today vs 20d2.39×
Avg vol (14d)277.84K
Avg vol (20d)256.76K
Avg $ vol (20d)3.17M
Market cap308.72M
RS 3m (vs SPY)-8.28%
RS 6m (vs SPY)+1.46%
RS line new highNo
Trend template7/8
Technical rank65.0
1 week+9.91%
1 month-2.45%
3 months+0.64%
6 months+9.01%
1 year+195.03%
YTD+17.34%
P/E-5.15
P/B1.23
P/S—
P/FCF-5.56
EPS-2.17
Div yield—
ROE-23.99%
ROA-22.95%
Debt/Eq—
Current38.00
EV/EBITDA-4.26
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-41.93%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value288.56M
Revenue0
Net income-14.46M
Gross profit—
Free cash flow-55.54M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out32.72M
Employees51
ListedFri, Apr 5, 2024
Free float26.58M
Float %81.2%
Short interest1.43M
Days to cover9.4d
Short volume43.9%
Squeeze score53 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.46 · 3 est
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction71 / 100
Pattern quality—
Tech rank65.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance15.30
Support11.17
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CTNM
No recent disclosed trades by Congress in CTNM. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CTNM · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Lorrain Daniel S. Chief Scientific Officer · Class A Common Stock · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-01 |
Lorrain Daniel S. Chief Scientific Officer · Class A Common Stock · 2026-06-01 | Sell | 4.17K | $55K | 2026-06-01 | 2026-06-01 |
Lorrain Daniel S. Chief Scientific Officer · Class A Common Stock · 2026-05-01 | Sell | 300 | $4K | 2026-05-01 | 2026-05-01 |
Lorrain Daniel S. Chief Scientific Officer · Class A Common Stock · 2026-05-01 | Sell | 3.87K | $51K | 2026-05-01 | 2026-05-01 |
Lorrain Daniel S. Chief Scientific Officer · Class A Common Stock · 2026-05-01 | Other | — | — | 2026-05-01 | 2026-05-01 |
SEC filings
EDGAR filings in CTNM · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.